2018 American Transplant Congress Archives - Page 211 of 211

Early Adjunctive Treatment with Human Cytomegaly Virus (CMV) Immunoglobulin Increased CMV-Free Survival after Heart Transplantation

M. Barten,¹ C. Neumaier,¹ A. Bernhardt,¹ M. Rybczynski,² R. Plaetke,³ H. Reichenspurner.¹
Early Allograft Biopsy in Kidney Transplant Recipients with DGF – Call for an Individualized Approach

A. Vijay, L. Barrison, M. Cooper, S. Ghasemian.
Early Association of Low Doses of Tacrolimus and a mTOR Inhibitor in BK Polyomavirus Infection in Kidney Transplant Recipients

V. Lopez,¹ T. Vazquez,¹ C. Jironda,¹ M. Cabello,¹ E. Sola,¹ M. Leon,² E. Marques,¹ D. Hernandez.¹
Early Biliary Complications after Orthotopic Liver Transplantation – Non-Randomised Comparison of 3 Methods of Biliary Tract Drainage

A. Jóźwik,¹ M. Kosieradzki,¹ B. Łągiewska,¹ W. Lisik,¹ E. Karpeta,¹ J. Bednarek,² M. Zaborska,² J. Trzebicki,³ M. Pacholczyk.¹
Early Blockade of Toll-Like Receptor 4 Reduces Ischemia-Reperfusion Injury and Improves Islet Transplantation Outcomes

C. Chang,¹ M. Lawrence,² R. Kane,¹ B. Naziruddin.³
Early Considerations for Deceased Donor Chains

A. Toll,¹ R. Leishman,¹ V. Casingal,² M. Aeder,³ T. Sandholm,⁴ N. Turgeon.⁵
Early Conversion to a CNI-Free Immunosuppression with SRL after Renal Tx – 10 yr Follow-Up Analysis of a Prospective Multicenter Trial

J. Andrassy,¹ M. Guba,¹ A. Habicht,² M. Fischereder,³ A. Pascher,⁴ K. Heller,⁵ B. Banas,⁶ O. Hakenberg,⁷ T. Vogel,⁸ T. Kauke.¹
Early Evolution and Pathologic Characteristics of Treg-Rich Organized Lymphoid Structures (TOLS) Associated with Immunological Tolerance in Accepted Mouse Kidney Allografts

C. Yang,¹ I. Rosales,² T. O'Shea,¹ D. Ndishabandi,² R. White,² P. Russell,¹ J. Madsen,¹ A. Alessandrini,¹ R. Colvin.²
Early Experience Using Donor-Derived Cell-Free DNA for Detection of Rejection in Kidney Transplantation

E. Huang, A. Vo, J. Choi, A. Peng, S. Sethi, R. Najjar, S. Jordan.
Early Graft Function Correlates with Survival Benefit in Kidney Transplant Recipients with Peripheral Vascular Disease

E. Min, V. Tatapudi, N. Ali, B. Gelb, N. Dagher, J. Benstein, R. Montgomery, B. Lonze.
Early Graft Losses in National PKE Programs: Gone, but Lost Forever?

J. Verbesey,¹ A. Waterman,² J. Veale,² S. Flechner,³ B. Javaid,¹ M. Ronin,⁴ G. Hil,⁴ C. Matthew.¹
Early Infectious Complications Post Total Pancreatectomy with Islet Autotransplantation

J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
Early Infectious Outcomes of Older Adults Undergoing Kidney Transplantation (KT). A Case Control Study

M. Hemmersbach-Miller,^1,2 K. Schmader.³
Early Life Stress Exposure and Cardio-Renal Outcomes in Pediatric Kidney Transplantation

M. Seifert, P. Perry, R. Romp, R. Mannon, J. Pollock.
Early Microcirculation Inflammation Associated with TCMR Leads to Poor Graft Outcomes in Kidney Transplant Recipients (KTRs)

A. Cherukuri, D. Chittka, R. Mehta, A. Sharma, P. Sood, S. Hariharan.
Early Outcomes and Risk Factors after Five Years of a Nationwide Strategy for Kidney Transplantation with Controlled Circulatory Death Donor (cDCD)

J. Portoles,^1,2 M. Perez Saez,² D. Hernandez,² J. Juega,² F. Moreso,² N. Maruri,² P. Lopez,^1,2 E. Melilli,² D. Navarro,² E. de Souza,² J. Ruiz,² M. Mazuecos,² A. Gutierrez,² I. Perez-Flores,² D. Janeiro,^1,2 J. Pascual.²
Early Postoperative Acute Kidney Injury among Pediatric Liver Transplant Recipients

H. Sahinturk,¹ A. Kundakci,¹ P. Zeyneloglu,¹ E. Gedik,¹ A. Pirat,¹ M. Haberal.²
Early Predictors of Metabolic Outcomes in TPIAT

M. Kanak,¹ Y. Shindo,¹ M. Levy.^1,2
Early Results from USHER: A Pilot Trial of Transplanting HCV-Infected Hearts into HCV-Negative Recipients Followed by Anti-Viral Therapy

R. McLean, P. P. Reese, M. Acker, P. Abt, A. Sicilia, N. Hornsby, P. Atluri, K. R. Reddy, E. Blumberg, V. Van Deerlin, D. S. Goldberg.
Early Steroid Withdrawal and Kidney Transplant Outcomes for Recipients with Delayed Graft Function

S. Bae, A. Massie, X. Luo, J. Garonzik Wang, D. Segev.
Early Steroid Withdrawal or Tacrolimus Minimization versus Standard Immunosuppression in Renal Transplant Recipients: The Allegro Trial

J. Sanders,¹ A. Gomes-Neto,¹ M. v Dijk,¹ M. v Sandwijk,² H. de Fijter,³ J. Homan vd Heide,² A. de Vries,³ F. Bemelman.²
Early Sub-Clinical and Clinical TCMR Are Associated with Progressive Renal Allograft Dysfunction

A. Cherukuri, D. Chittka, R. Mehta, P. Sood, S. Hariharan.
Early Utilization of Telehealth in Kidney Transplantation

T. Young, D. Hricik, E. Sanchez, N. Sarabu.
Early versus Late Cytomegalovirus Prophylaxis after Kidney Transplant

M. Harris, J. Byrns, J. Gommer, M. Laub, M. Ellis.
Economic Evaluation of Contemporary Kidney Transplant Practice

D. Axelrod,¹ M. Schnitzler,² H. Xiao,² W. Irish,³ J. Tuttle-Newhall,³ S-.H. Chang,⁴ B. Kasiske,⁵ T. Alhamad,⁴ K. Lentine.²
Eculizumab for the Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients: A Single Center Experience

A. Chi, J. Phillips, D. Quan.
Effect and Reasons of Rescue Switch to Belatacept among 73 Calcineurin-Inhibitors Treated Kidney Allograft Recipients – A Three Years Retrospective Cohort, Single Center Study

M. Matignon,¹ C. Dudreuilh,¹ P. Rémy,¹ D. Desvaux,² P. Grimbert.¹
Effect of De Novo Use of Everolimus with Reduced Calcineurin Inhibitor versus Standard Mycophenolic Acid-Based Regimen on Wound Healing Events in Kidney Transplant Recipients from TRANSFORM Study

M. Henry, F. Citterio, M. Kim, D. Kim, P. Bernhardt, A. Gupta, Y. Watarai.
Effect of Acute Vascular Inflammation (v) on Death Censored Graft Failure (DCGF) Following Kidney Transplant (KTx)

J. Grande,¹ L. Hunsicker,² R. LeDuc,³ A. Matas, The DeKAF Consortium.
Effect of Belatacept on Late Acute Rejection Episodes and Graft Loss in Young Adults between the Ages of 18-24 Years: Post-Hoc Analysis of BENEFIT Study

A. Moudgil.
Effect of Conversion to CTLA4Ig Treatment on Tacrolimus-Induced Diabetic Rats

J. Il,¹ L. Jin,¹ K. Luo,¹ S. Lim,¹ Y. Shin,¹ E. Ko,^1,2 B. Chung,^1,2 C. Yang.^1,2
Effect of Direct-Acting Hepatitis C Treatment Regimens on Calcineurin Inhibitors in Liver and Kidney Transplant Patients

M. Laub, J. Byrns, M. Harris, C. Berg, S. Sanoff.
Effect of Donor-Recipient Gender-Mismatch on Long Term Function after Pancreas Transplantation

F. Messner,¹ C. Bösmüller,¹ M. Maglione,¹ M. Riedmann,² R. Oberhuber,¹ B. Cardini,¹ T. Resch,¹ S. Schneeberger,¹ C. Margreiter.¹
Effect of Early Attainment of Everolimus Target Trough Levels on Efficacy-Safety Outcomes in De Novo Kidney Transplant Recipients: 12-Month Results from US92 and TRANSFORM Studies

F. Shihab,¹ Y. Qazi,^1,2 V. Peddi,¹ D. Shaffer,¹ D. Kim,^1,2 K. McCague,³ D. Patel,³ S. Mulgaonkar.^1,2
Effect of Erythropoietin on Cardiac Allograft Survival in Non-Human Primates

J. O.,¹ K. Robinson,¹ W. Sommer,¹ K. Pruner,¹ J. Paster,¹ M. Hanekamp,¹ A. Dehnadi,¹ I. Rosales,¹ R. Smith,¹ P. Cravedi,² P. Heeger,² G. Benichou,¹ J. Madsen.¹
Effect of Ethnicity on Recipient Characteristics, Kidney Transplant Provision and Outcomes in a High-Volume National Health Service Hospital

E. Favi,¹ C. Puliatti,² M. Ferraresso,¹ R. Cacciola.²
Effect of Everolimus on Body Composition; 1-Year after Kidney Transplantation

M. Yoshikawa,¹ T. Ishimura,² S. Nishi.¹
Effect of Everolimus with Reduced Calcineurin Inhibitor on Efficacy and Safety in De Novo Kidney Transplant Recipients: 12-Month Results from the US Cohort of TRANSFORM Study

S. Mulgaonkar,¹ Y. Qazi,¹ D. Kim,¹ V. Peddi,¹ K. McCague,² D. Patel,² A. Wiseman.¹
Effect of Functional and Cognitive Impairment on Readmissions in Geriatric Renal Transplant Recipients

T. Uemura,¹ V. Rodriguez,¹ G. Rosen,² S. Lerner,² O. Apoeso.¹
Effect of HLA Antibodies on Graft Survival in Adult Live Donor Liver Transplantation

M. Simpson,¹ M. Akoad,¹ F. Gordon,¹ Y-.L. Cheah,¹ C. Simon,¹ J. Pomposelli,² E. Pomfret.²
Effect of Induction Therapy on CD4 Cell Count Recovery Following Renal Transplantation in HIV Positive Recipients – A Single Center Experience

J. Chique Figueroa, M. Prendergast, H. Wadei, M. Mai, K. Oshel, D. Leonard.
Effect of Influenza Vaccine in Patients with Kidney Transplant

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²
Effect of Kidney Allocation System on a Solitary, Isolated, Rural Transplant Program

K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² J. Africa.¹
Effect of rATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

Y. Jiang, X. Zhang.
Effects of a Multimodal Pain Control Regimen in Living Donor Laparoscopic Nephrectomies

E. Thomas, J. Nelson, E. Diaz.
Effects of Health Literacy and Numeracy Literacy on Adherence, Quality of Life and Readiness to Transition in Pediatric Renal Transplant Recipients

M. Kamel,¹ C. McCracken,¹ A. Wilkerson,¹ N. Alexander,¹ J. Gazmararian,² R. George.¹
Effects of IdeS on HLA-SAB, C1q-SAB and CDC-XM

S. Järnum,¹ A. Runström,¹ L. Winstedt,¹ T. Lorant,² C. Kjellman.¹
Effects of Medication Education Pilot Program in Living versus Deceased Donor Kidney Transplant Recipients.

N. Sulejmani, H. Albanna, B. Summers, A. Jantz, R. Prashar, A. Patel.
Effects of Preformed Antibody on Survival Following Pig-to-Primate Liver Xenotransplantation

N. Louras, M. Patel, J. Shah, A. Andrews, Z. Wang, D. Sachs, P. Vagefi.
Effects of Sarcopenia on Patients Undergoing Liver Re-Transplantation

J. Stracke, M. Ilias, S. Nagai.
Effects of the Addition of Mycophenolate Mofetil on Renal Outcomes in Liver Transplant Recipients: A Single Center Review

M. Henry, M. Vacha.
Efficacy and Safety of a Single-Dose Rituximab for Prevention of Focal Segmental Glomerulosclerosis Recurrence after Kidney Transplant

Y. Lu,¹ J. Lyons,² S. Tischer,² K. Woodside,³ J. Park.²
Efficacy and Safety of Acute Antibody Rejection Treatment in Pediatric Kidney Transplant Recipients

E. Kincaide,^1,2,3 K. Hitchman,^1,3 R. Hall,^1,2,3 I. Yamaguchi,³ B. Crowther.^1,2,3
Efficacy and Safety of Bleselumab in Kidney Transplant Recipients: A Phase 2, Randomized, Open-Label Study

R. Harland,¹ G. Klintmalm,² S. Jensik,³ H. Yang,⁴ J. Bromberg,⁵ J. Holman,⁶ M. Anil Kumar,⁶ V. Santos,⁶ T. Larson,⁶ X. Wang.⁶
Efficacy and Safety of Immediate- and Prolonged-Release Tacrolimus in De Novo Pediatric Transplantation: Randomized Study

K. Vondrak,¹ F. Parisi,² A. Dhawan,³ R. Grenda,⁴ N. Webb,⁵ S. Marks,⁶ D. Debray,⁷ R. Holt,⁸ A. Lachaux,⁹ D. Kelly,¹⁰ G. Kazeem,¹¹ N. Undre.¹¹
Efficacy and Safety of Tocilizumab in Treatment of Acute Antibody Mediated Rejection

K. Venkatachalam, D. Reem, M. Andrew, R. Delos Santos, T. Alhamad.
Efficacy of At-Home Transplant Education on Transplant Knowledge and Pursuit in Low-Income and Black Dialysis Patients with Varying Educational Characteristics

A. Waterman,^1,2 J. Peipert,^1,2 J. Beaumont.²
Efficacy of Bronchoscopically-Administered Surfactant in the Setting of Primary Graft Dysfunction after Lung Transplantation

S. Ahmed,¹ M. Soto-Arenall,¹ D. Jackson,¹ D. Erasmus.²
Efficacy of Current Educational Interventions in Improving Living Donor Kidney Transplantation Rates

S. Sandal, N. Dendukuri, S. Wang, E. Guadagno, T. Ekmekjian, A. Alam.
Efficacy of Generic Sofosbuvir and Branded Daclatasvir Compared to Sofosbuvir and Ledipasvir Combination in the Treatment of Genotype 4 Hepatitis C Virus

H. Joharji, A. Al-Jedai, D. Alkortas, A. Ajlan, E. Devol, M. Ahmed, F. Aba Al-Khail, H. El-Siesy, M. Al-Sebayel, H. Al-Ashgar, M. Al-Quaiz, W. Alhomodi, A. Aloubal, A. Almohishir.
Efficacy of IVIG + Rituximab Desensitization Therapy on HLA Antibodies is Independent of HLA Loci

X. Zhang,¹ S. Jordan.²
Efficacy of Two Valganciclovir Dosing Strategies in Intermediate and High-Risk Liver Transplant Recipients

K. Belfield,¹ M. Malinis,² E. Cohen.¹
Elbasvir-Grazoprevir (Zepatier) is Effective and Safe for the Treatment of Chronic Hepatitis C (HCV) Genotype 1 Virus in the Post Kidney Transplant Patient

P. Brown, D. Venkat.
Elevated Donor Terminal Creatinine Does Not Appear to Be Associated with Worse Outcomes in Kidney Transplantation

S. Rayhill, J. Haldorson.
Elevated Levels of CD19⁺ B Cells before or after Rituximab Administration is a Risk Factor for the Early Rejection of a Living Kidney Transplant

M. Kono,¹ H. Shirakawa,² S. Wakai.¹
Elevated Serum Penteraxin in Cardiac Allograft Antibody Mediated Rejection: From Cytokine Arrays to Patients with ABMR

O. Moussa,³ M. Kavarana,² L. Klingman,¹ J. Felius,¹ S. Hall,¹ M. Askar.¹
Elevated Skin Specific Non-HLA Antibodies Correlate with Acute Rejection Episodes in Clinical VCA

B. Kollar,¹ A. Uffing,² T. Win,¹ S. Tasigiorgos,¹ B. Pomahac,¹ F. Quintana,³ L. Riella.²
Eluates from Fine-Needle Allograft Biopsy Increase Donor-Specific Antibody Identification in Antibody Mediated Rejection

A. Girnita,^1,2 E. Portwood,² P. Brailey,² M. Cuffy,¹ M. Cardi,¹ F. Paterno,¹ T. Diwan,¹ S. Shah,¹ A. Govil,¹ R. Alloway,¹ E. Woodle.¹
Elucidating Novel Signatures of Allograft Rejection through Cytometry by Time of Flight (CyTOF) in Kidney Transplant Recipients

S. Eskandari,¹ B. Al Dulaijan,¹ J. Assaker,¹ L. Riella,¹ A. Kurdi,² J. Azzi.¹
Emergence of a Costimulation-Susceptible T Cell Repertoire Post-Alemtuzumab Induction

Q. Gao,¹ A. Mehta,² A. Guasch,² L. Stempora,¹ A. Kirk,¹ H. Xu.¹
End Stage Kidney Disease Risk Profile in Living Kidney Donors for Pediatric versus Adult Kidney Transplant Recipients in Australia and New Zealand

D. Lee,^1,2 J. Whitlam,² N. Cook,² A. Walker,³ F. Ierino,⁴ M. Roberts,¹ J. Kausman.³
End Stage Renal Disease after Face Transplant

N. Shockcor,¹ B. Buckingham,¹ W. Hassanein,¹ A. Haririan,¹ S. Roberts,² A. Nam,¹ E. Rodriguez,³ S. Bartlett,¹ R. Barth.¹
Endoplasmic Reticulum Stress Sensor IRE1α Deficiency Promotes Infiltrating Macrophage Polarization and Induces Long-Term Renal Allograft Acceptance in Mice

L. Qiu,¹ J-.J. Wang,¹ X. Yeap,¹ D. Fang,² J. Zhang.¹
Endothelial Cell Heterogeneity Governs Basal and Inducible Inflammatory Responses Relevant to Allograft Injury

N. Valenzuela.
Endothelial Progenitor Cell-Derived Extracellular Vesicles Inhibit Kidney Ischemia-Reperfusion Injury through the Transfer of Specific microRNA and mRNA Coding for the Complement Inhibitors CD55, CD59, Factor H and for the Transcription Factor NRF2: Relevance for Delayed Kidney Graft Function

V. Cantaluppi,¹ D. Medica,¹ S. Dellepiane,¹ G. Merlotti,¹ A. Airoldi,¹ M. Quaglia,¹ G. Castellano,² L. Gesualdo,² G. Camussi.³
Endothelin A Receptor (ETaR) siRNA Ameliorates Renal Ischemia Reperfusion Injury through Upregulating Expression of eNOS in Rats

Y. Jia, L. Li, T. Zhu.
Endothelin-1 Type A Receptor Antibodies Are Associated with Elevated Il-8, Arteritis and Decline in Renal Function in Pediatric Renal Transplant Recipients

M. Pearl,¹ J. Grotts,¹ M. Rossetti,¹ Q. Zhang,¹ P. Weng,¹ E. Reed,¹ E. Tsai Chambers.²
Engineering Regulatory T Cells with Interleukin (IL-)2 Nanogel for Improved Alloimmune Suppression

S. Eskandari,¹ M. Bandeira Melo,² J. Assaker,¹ A. Mansouri,¹ S. Cai,¹ B. Al Dulaijan,¹ M. Mohamed,¹ D. Irvine,² J. Azzi.¹
Enhanced Recovery after Kidney Transplantation Regardless of Donor Organ Source

O. Ojogho,¹ S. BaniHani,¹ S. Nemr,¹ B. Dieter,² A. Joyce,¹ J. Mejia.¹
Enhanced Recovery after Renal Transplant Surgery Using a Transversus Abdominis Plane Block is Associated with Decreased Hospital Length of Stay

D. Peramunage, D. Auyong, C. Kuhr, J. Brandenberger, N. Cowan, N. Hanson.
Enhancement of Endogenous omega-3 Protect against Ischemia-Reperfusion Renal Injury in Fat-1 Mice

D. Choi,¹ Y. Ham,¹ K. Na,¹ K. Lee,¹ J-.J. Kim,^1,2 J. Jeong.^1,3
Enhancement of Intrinsic Apoptosis via Bcl-2 Inhibition Promotes Induction of Robust Mixed Chimerism and Renal Allograft Tolerance without Myelosuppression in Nonhuman Primates

T. Oura,¹ A. Dehnadi,¹ I. Rosales,¹ H. Sasaki,¹ P. Cippa,² R. Fehr,² A. Cosimi,¹ T. Kawai.¹
Enhancement of Muscle Regeneration and Function via Transplantation of Human Dystrophin Expressing Chimeric Cells as a Novel Myoblast Stem-Cell Based Therapy

M. Siemionow,¹ J. Cwykiel,¹ E. Marchese,¹ G. Rafidi,¹ K. Futoma,¹ A. Heydemann,² J. Garcia-Martinez,² E. Szilagyi.¹
Enhancing Coordination across Healthcare Settings through a Web-Based Transplant Referral Exchange (T-REX) Platform

L. McPherson,¹ R. Mutell,² P. Broughton,² M. Basu,¹ J. Gander,¹ S. Pastan,¹ R. Patzer.¹
Enrichment of Endogenous Donor-Reactive Tregs in the Spleen and Graft during Transplantation Tolerance is the Result of Treg Proliferation and Conversion from Tconv

J. Young, D. Yin, M-.L. Alegre, A. Chong.
Enteric Conversion after Bladder-Drained Pancreas Transplantation: The Wisconsin Experience

J. Adler, R. Redfield, D. Kaufman, J. Odorico, H. Sollinger.
Enteric Conversion of Bladder Drained Pancreas as a Time Dependent Predictor of Outcomes in over 900 Recipients

S. Riad,¹ D. Keys,¹ V. Vakil,¹ S. Jackson,² D. Berglund,² A. Matas,³ R. Kandaswamy.³
Epitope/Eplet Mismatch in Pediatric Renal Transplantation and Development of Donor Specific Antibody

R. George,¹ H. Sullivan,² R. Garro,¹ P. Winterberg,¹ B. Warshaw,¹ H. Gebel,² R. Bray.²
Eplet Mismatches and De Novo Donor Surface Antibody Development in Pediatric Renal Transplant Recipients

E. Blanchette,¹ M. Bradford,¹ P. Warner,² C. Blosser,³ I. Gimferrer,² J. Smith.¹
Equivalent Clinical Outcomes and Stable Post-Operative Anti-A IgG Titers in A2 to B Renal Transplant Recipients Compared to Matched B to B Cohort

C. Barnhill,¹ P. Warner,² A. Weiss,¹ C. Kuhr,¹ N. Cowan,¹ J. Brandenberger.¹
Equivalent Post-Donation eGFR after Robotic Assisted versus Laparoscopic Living Donor Nephrectomy

R. Cross, H. Pollinger, M. Tan, M. Mulloy, T. Ommert, A. Ray, C. Klein.
Estimated GFR at Donor Screening and Achieved Measured GFR after Living Kidney Donation

M. van Londen, J. van der Weijden, S. Bakker, S. Berger, J. Sanders, G. Navis, M. de Borst.
Estimated GFR for Living Kidney Donor Evaluation before and after Donor Nephrectomy

Y. Kakuta,¹ M. Okumi,¹ R. Imamura,² N. Ichimaru,² S. Takahara,² H. Ishida,¹ K. Tanabe.¹
Estimated Impact of the Number of Simultaneous Offers on Kidney Delay and Discard

M. Mankowski,¹ S. Raghavan,³ C. Holscher,² M. Kosztowski,² D. Segev,² S. Gentry.⁴
Estimation of Beta Cell Function after Total Pancreatectomy with Islet Autotransplantation Using Single Fasting Blood Sample Based Indices and Modified Igls Score.

J. Gołębiewska,¹ P. Bachul,² L. Basto,² M. Kijek,² N. Fillman,² K. Cieply,² K. Golab,² L. Wang,² M. Tibudan,² C. Thomas,³ A. Dębska-Ślizień,¹ J. Fung,² P. Witkowski.²
Estimation of Mortality on the Wait List

S. Asrani, L. Jennings, J. Trotter, G. Klintmalm.
Ethnic and Age Disparities in Outcomes among Liver Transplant Waitlist Candidates

M. Mustian,¹ S. Gray,¹ B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ J. White,¹ D. Eckhoff,¹ R. Allman,² J. Locke.¹
Ethnic Disparities in Elderly Patients Receiving Kidney Transplantation

I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud.
Etiologies and Long-Term Outcomes of Acute Kidney Injury in Older Kidney Transplant Recipients

R. Rodriguez, P. Amechi, V. Rao, D. Taber, M. Posadas Salas.
Evaluating Center Performance beyond Patient and Graft Survival

S. Asrani, G. Saracino, R. Bahirwani, G. McKenna, G. Klintmalm, J. Trotter.
Evaluating Displays of Program Waitlist Mortality on Public Search Results

C. Schaffhausen,^1,4 M. Bruin,³ S. Chu,³ A. Matas,⁵ J. Lake,⁶ W. Kim,^7,4 S. Biggins,⁸ J. Snyder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
Evaluating PROMIS-57 Domains to Screen for Anxiety and Depression Using Legacy Instruments among Kidney Transplant Recipients

A. Bansal,¹ O. Ekundayo,¹ E. Tang,¹ F. Khalafi,¹ H. Ford,¹ M. Li,³ M. Novak,² I. Mucsi.¹
Evaluating the Impact of Pre-Transplant Malignancy on Outcomes after Kidney Transplantation: A National Database Analysis over a Twenty-Two Year Period

D. Livingston-Rosanoff, L. Wilke, G. Leverson, D. Foley.
Evaluating Transplant Quality Staffing Models via a National Survey

M. Cook, I. Feurer, L. Smith, S. Rega, E. Zavala.
Evaluation and Cost Burden of Inappropriately Drawn Immunosuppression Trough Levels in the Acute Care Setting at an Academic Medical Center

A. Brown, J. Geyston, A. Agarwal, B. Jones, W. Ally.
Evaluation of a Change in CMV Prevention Strategy Following Pediatric SOT

S. Pangonis, A. Miethke, F. Flores, M. Schecter, S. Kocoshis, D. Lazear, T. Hemmelgam, B. Taylor, G. Paulsen, L. Danziger-Isakov.
Evaluation of a Marine OXYgen Carrier (Hemo2Life®) for Organ Preservation: First Use in Kidney Transplantation in Humans

Y. Le Meur,¹ E. Morellon,² M. Essig,³ A. Thierry,⁴ M. Buchler,⁵ S. Drouin,⁶ C. Deruelle,¹ L. Badet,² F. Pesteil,³ P-.O. Delpech,⁴ J-.M. Boutin,⁵ B. Barrou.⁶
Evaluation of Accepting Kidneys of Varying Quality for Transplantation or Expedited Placement with Decision Trees

S. Mehrotra,¹ H. Gordon,¹ K. Bui,¹ J. Friedewald,² D. Ladner,² B. Kaplan,⁴ V. Kilambi.³
Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients with a History of Macrolide Antibiotic Allergy

J. Trofe-Clark,^1,2 M. Doshi,³ O. Fadugba,⁴ M. Lim.²
Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients

A. Lichvar,¹ S. Tremblay,² D. Naik,² E. King,⁴ A. Vinks,⁴ U. Christians,³ J. Lipscomb,⁴ R. Alloway.²
Evaluation of Culture/Preservation Conditions on Human Islet Survival and Function

Y. Shindo,¹ M. Levy,^1,2 M. Kanak.¹
Evaluation of Drug Action on IgM Memory B Cell Survival and Growth In Vitro; -Application for Individualized Immunosuppression after Kidney Transplants-

Y. Matsuda,¹ K. Takahashi,¹ R. Imamura,² N. Nonomura,² Y. Yuzawa.¹
Evaluation of Efficiency and Patient Perception of Solid Organ Transplant Medication Education after Pharmacist-Created Video Education

Y. Mitchell, J. Volpendesta, J. Vongspanich-Dray.
Evaluation of Financial Well-Being of Living Kidney Donor Candidates

S. Singh,^1,2 G. Bannerman,² A. Yantsis,² M. Liu,² F. Gumabay,² O. Famure.²
Evaluation of FlowDSA Crossmatch for Detection of Donor-Specific HLA Antibodies

J. Lee, J. Ryu, A. Choi, E-.J. Oh.
Evaluation of Hepatitis B Vaccination in Transplant Candidates

M. Bosaeed, Y. AlJishi, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Evaluation of Immunosuppression and Infection after Desensitization in Lung Transplantation

S. Hammad, B. Ravichandran, J. Kim, D. KuKuruga, S. Cipriano, Z. Kon.
Evaluation of KPD: Does It Improve Overall Transplant Center Performance?

M. Rees,³ E. Michelin,¹ N. Koizumi,² J. Ortiz.³
Evaluation of MPA Dose on Development of DSA Following Pancreas Transplant

J. Descourouez,¹ M. Jorgenson,¹ A. Twigg,¹ G. Leverson,² J. Odorico,³ R. Redfield.³
Evaluation of Multiple Linear Regression Limited Sampling Strategies for Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

C. Staatz,¹ E. Brooks,¹ N. Isbel,² B. McWhinney,³ S. Tett.¹
Evaluation of Risk Factors for Progression of Low Level CMV Viremia in Solid Organ Transplant Recipients

Y. Natori, A. Humar, A. Alghamdi, D. Kumar.
Evaluation of Risk Factors for Vancomycin Resistant Enterococcus (VRE) Infection in Adult Liver Transplant Recipients

E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, L. Fehrenbacher, D. Kramer.
Evaluation of Salt Intake by 24-h Urinary Sodium Excretion in Kidney Transplant Patients

T. Abe,¹ M. Kawamura,¹ S. Nakazawa,¹ T. Kato,¹ R. Imamura,¹ N. Ichimaru,² S. Takahara,² N. Nonomura.¹
Evaluation of Survival and Maintenance Immunosuppression in Elderly Lung Transplant Recipients

P. Nguyen,¹ R. Girgis,^1,2 E. Murphy,^1,2 R. Hadley,^1,2 M. Leacche,^1,2 A. Kumar,^1,2 G. Sathiyamoorthy,^1,2 J. McDermott.^1,2
Evaluation of Tacrolimus Extended-Release in African American Renal Transplant Recipients

T. Sparkes, B. Ravichandran, C. Williams, B. Thomas, B. Masters.
Evaluation of the Use of Oral Valganciclovir for the Treatment of Cytomegalovirus Infections in Pediatric Intestinal Transplant Recipients: A Single Center Review

M. Henry, M. Vacha, M. Keck, D. Florescu.
Evaluation of Transplant Kidneys Using a Novel Point of Care 3D Ultrasound System

J. Salinaro,¹ J. Broder,¹ E. Jaffa,¹ M. Morgan,¹ D. Vikraman-Sushama,¹ J. Dahl,² C. Herickhoff,² A. Limkakeng,¹ E. Peethumnongsin,¹ J. Borawski.¹
Evaluation the Outcomes of Liver Transplant Recipients Underwent Splenectomy: A Meta-Analysis

M. Chen, X. Lin, B. Huang, X. He.
Evanescent Antibodies: A Report on the Natural History of Anti-Blood Group A₂ Antibodies and Their Rapid Resolution in Patients Awaiting A₂ to B Transplantation

S. Radomski, S. Rosen-Bronson, D. Li, M. Awwad, G. Vranic, B. Javaid, P. Abrams, S. Yi, M. Cooper, A. Gilbert.
Everolimus and the Risk of Graft Loss or Death in Kidney Transplant Recipients: A Trial-Based Linkage Study

T. Ying,^1,2 G. Wong, W. Lim, G. Russ, H. Pilmore, J. Kanellis, D. Goodman, P. Trevillian, S. Campbell, M. Suranyi, M. Mathew, R. Faull, R. Masterson, R. Walker, P. O'Connell, S. Chadban.^1,2
Everolimus with Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplant Recipients: Efficacy and Safety Outcomes from the TRANSFORM Study

S. Mulgaonkar,¹ J. Pascual,¹ S. Chadban,¹ H. Tedesco,¹ S. Berger,¹ Y. Qazi,¹ C. Legendre,¹ N. Basic-Jukic,¹ P. Bernhardt,² F. Vincenti.¹
Everolimus with Reduced-Dose Calcineurin Inhibitor versus Mycophenolate with Standard-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Renal Function Results from the TRANSFORM Study

F. Oppenheimer,¹ C. Legendre,¹ J. Cruzado,¹ G. Russ,¹ O. Viklicky,¹ R. Oberbauer,¹ V. Garcia,¹ O. Witzke,¹ D. Kuypers,¹ R. Danguilan,¹ P. Bernhardt,² C. Sommerer.¹
Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report

A. Leino,¹ C. Emoto,² T. Fukuda,² M. Privitera,¹ A. Vinks,^1,2 R. Alloway.¹
EVLP on Donor Lungs: National Trends and Outcomes

R. Lehman,¹ R. Carrico,¹ K. Uccellini,¹ K. Chan,² T. Whelan.³
Evolution of Very Old Donor Grafts

S. Jiménez Alvaro,¹ A. Fernández Rodriguez,¹ C. Galeano Alvarez,¹ S. Elías Treviño,¹ J. Burgos,² F. Liaño García.¹
Evolutive Analysis of a 20-Year Pancreas Transplant Program

M. Perosa,¹ J. Branez,¹ L. Mota,¹ H. Noujaim,¹ B. Zeballos,¹ L. Ianhez,¹ L. Alvim,¹ D. Machado,¹ C. Watanabe,¹ F. Sergi,¹ M. Paredes,¹ T. Genzini-Miranda,² A. Silvestre,³ G. Martinho,⁴ T. Genzini.¹
Evolving Etiologies for Readmissions and Their Impact on Graft Survival in Kidney Transplantation

D. Taber, N. Pilch, Z. Su, C. Mardis, J. Fleming, N. Patel, H. Meadows, P. Mauldin, V. Rao, D. Dubay.
Evolving Trends in Demographic and Medical Characteristics of Liver Transplant Recipients

R. Rosenblatt,¹ N. Shen,¹ Z. Tafesh,¹ B. Fortune,¹ K. Halazun,¹ A. Jesudian.¹
Ex Vivo Expanded Regulatory T Cells Combined with Short-Term Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts

B. Oh,¹ G. Furtmüller,¹ M. Grzelak,¹ L. Vuong,² M. Iglesias,¹ M. Fryer,¹ D. Cooney,¹ W. Lee,¹ G. Raimondi,¹ G. Brandacher.¹
Ex Vivo Lung Perfusion Using the Portable OCS Maintains Endothelial Integrity in the Context of Reduced Severe PGD Rates

B. Wiegmann,¹ R. BellmasSanz,² C. Neudörfl,² C. Kühn,¹ I. Tudorache,¹ M. Avsar,¹ A. Haverich,¹ G. Warnecke,¹ C. Falk.²
Ex-Situ Normothermic Human Upper Extremity Perfusion: Preliminary Report

V. Fahradyan, E. Dalla Pozza, M. Madajka, K. Cho, N. Dawlagala, E. Duraes, H. Shah, S. Al-deen Said, C. Ordenana, F. Papay, A. Rampazzo, B. Bassiri Gharb.
Ex-Vivo Generation of Alloantigen-Specific Immunomodulatory Cells: Elucidating the Mechanistical Synergy of Cell Components

M. Yao,¹ M. Kumagai-Braesch,¹ M. Watanabe,^1,2 K. Tokodai,¹ T. Lundgren,¹ M. Uhlin,¹ B. Ericzon.¹
Ex-Vivo Pretreatment of Islets with Mitomycin-C Have a Potential to Induce Specific Immune Response for Peripheral Tolerance

N. Sato, A. Kenjo, T. Kimura, R. Okada, T. Ishigame, Y. Kofunato, J. Watanabe, M. Muto, S. Suzushino, T. Shimura, S. Marubashi.
Ex-Vivo Subnormothermic Oxygenated Machine Perfusion of Rodent Hindlimb: Feasibility Study to Elongate Preservation Time of Vascularized Composite Allograft

L. Burlage,^1,2 A. Lellouch,^3,4 S. Tessier,¹ C. Pendexter,¹ S. Cronin,¹ M. Schol,³ M. Randolph,³ R. Porte,² L. Lantieri,⁴ C. Cetrulo,³ K. Uygun.¹
Examples of the Observer Effect in Transplantation- Unintended Consequences of Regulation and Selected Outcome Metrics

A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss.
Excellent Long Term Outcomes Transplanting Single Pediatric Kidneys from Donors Five Years and Younger into Adult Recipients

R. Shah,¹ M. Aull,² A. Watkins,² S. Kapur.²
Excellent Long-Term Outcomes with Kidney Transplants from Deceased Donors with Acute Kidney Injury

G. Dube, S. Husain, D. Cohen, S. Mohan.
Excellent Outcomes for HCV-Viremic Recipients of Simultaneous Liver-Kidney Transplant in the Direct Anti-Viral Era

A. Ray, C. Klein, T. Ommert, R. Cross, R. Rubin.
Exenatide Reduces Ischemia/Reperfusion Injury in Donation after Cardiac Death Rat Kidney Transplantation

H. Yang,¹ Y. Shi,² X. Li,¹ C. Long,¹ Z. Xu,¹ L. Luo,¹ W. Luo,¹ Y. Zhang,¹ T. Zeng,³ M. Chen,⁴ H. Li,⁵ Z. Wang.⁵
Exercise Rehabilitation's Effect on Employment and School Rates in Kidney Transplant Patients

A. Kastelz,^1,2 C. Di Bella,¹ I. Tzvetanov,¹ B. Fernhall,² L. Gallon,³ G. Hachaj,⁴ E. Benedetti.¹
Exosomes from Umbilical Cord-Derived Mesenchymal Stem Cells on Hepatocytes Proliferation after Small-for-Size Liver Transplantation via RHO/ROCK Pathway

L. Chen, J. Zheng, J. Cai, J. Yao, K. Zeng, Y. Zhang, Y. Yang.
Experience and Safety of Hand-Assisted Laparoscopic Nephrectomy for Living Kidney Donors at Mexico´s General Hospital "Dr. Eduardo Liceaga"

P. Prieto-Olivares, L. Garcia-Covarrubias, A. Bahena-Portillo, A. Cicero-Lebrija, V. Visag-Castillo, H. Hinojosa-Heredia, D. Fernandez-Angel, Y. Carrión, A. Rosas, E. Pedraza, I. Castro, A. García-Covarrubias, H. Diliz-Perez.
Experience in the Development of a Life-Supporting Large Animal Orthotopic Cardiac Xenotransplant Model

L. DiChiacchio,¹ A. Singh,¹ B. Lewis,¹ E. Strauss,¹ P. Odonkor,¹ B. Williams,¹ D. Ayares,² K. Deatrick,¹ Z. Kon,¹ M. Mohiuddin.¹
Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage

D. Harriman, A. Farney, J. Rogers, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Experience with Immunosuppressive Strategies in Vascularized Composite Allotransplantation of Face

R. Klasek,¹ B. Kollar,² S. Tasigiorgos,² B. Pomahac.²
Experiences, Perceptions, and Concerns about Successful Aging among KT Candidates and Recipients

F. Warsame, S. Rasmussen, A. Eno, A. Mountford, C. Haugen, M. McAdams-DeMarco, D. Segev.
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Recipients

D. Goodall, M. Willicombe, A. McLean, D. Taube.
Exploring the Impact of Recipient Age with Kidney Donor Risk Index and Estimated Glomerular Filtration Rate at One Year Following Kidney Transplant

S. Chan,^1,2,3 M. Chatfield,⁴ K. Baboolal.^2,3
Exploring the Viability of Kidneys Discarded in the US: A Comparison of Kidney Utilization Patterns and Outcomes in the US and France

O. Aubert, P. Reese, M. Raynaud, D. Viglietti, C. Loheac, N. Kamar, M. Delahousse, C. Legendre, D. Glotz, C. Lefaucheur, A. Loupy.
Expression of the Senescence Marker P16/INK4A in Kidney Implantation Biopsies is Uniquely Associated with Poor Late Graft Function

K. Famulski, P. Halloran.
Extended Criteria Donors Have Higher Expression of Inflammatory Genes Than Standard Donors

M. Abbud-Filho,^1,2,3 M. Fernandes-Charpiot,^1,2 M. Baptista,^1,2 H. Caldas,^1,2 G. Florim.¹
Extended Experience Using Tocilizumab (Anti-IL6R, TCZ) for the Treatment of Chronic Antibody Mediated Rejection (CABMR)

J. Choi,¹ O. Aubert,² S. Louie,¹ N. Ammerman,¹ A. Vo,¹ A. Peng,¹ E. Huang,¹ R. Najjar,¹ D. Puliyanda,¹ S. Sethi,¹ M. Haas,¹ K. Lim,¹ A. Loupy,² S. Jordan.¹
External Validation of Hennepin Transplant Risk Score for Prediction of Short-Term Mortality and Morbidity after Deceased Kidney Transplantation

A. Velioglu,^1,2 M. Vijayan,¹ H. Shin,^1,3 J. Perry,¹ A. Chandraker.¹
Extra-Renal Effects of Estrogen Receptor-Alpha Mediate Protection from Renal Ischemia-Reperfusion Injury

D. Aufhauser, D. Murken,¹ S. Concors,¹ Z. Wang,¹ G. Ge,¹ T. Bhatti,² W. Hancock,^2,3 M. Levine.¹
Extracellular Matrix from Pancreas Improves Human Islet Function In Vitro

Y. Shindo,¹ R. Pouillot,² B. Young,² P. Link,² R. Heise,² M. Levy,^1,3 M. Kanak.¹
Extracellular Microvesicles from Liver Perfusate: microRNAs, Cellular Cross-Talk, and Early-Post Liver Transplant Outcomes

A. Fernandez,¹ O. Ingram,¹ S. Bontha,¹ U. Erdbruegger,² L. Musante,² V. Mas,¹ D. Maluf.¹
Extracellular Vesicles Derived from Huc-MSCs Alleviate Rat Hepatic Ischemia-Reperfusion Injury by Suppressing Oxidative Stress and Neutrophil Inflammatory Response

J. Yao,^1,2 J. Cai,^1,2 J. Zheng,^1,2 L. Chen,^1,2 Y. Zhang,^1,2 Y. Yang.^1,2
Extracorporeal Membrane Oxygenation Experience for Graft Failure after Heart Transplantation

S. Lehmann, K. Jawad, S. Feder, A. Meyer, M. Dieterlen, J. Fischer, J. Garbade, M. Borger.